GLP-3 RT 30mg (Retatrutide)

Description

GLP-3 RT 30mg is Nexopep’s high-volume format of Retatrutide, providing 30mg of this advanced triple agonist peptide per vial. Designed for extended research programmes or multi-subject protocols, this format offers significant cost efficiency for large-scale metabolic research. Retatrutide’s triple receptor activity (GLP-1, GIP, glucagon) makes it one of the most comprehensively studied anti-obesity research peptides available. Third-party COA available. For laboratory research use only.